Systemic therapy for colorectal cancer
JA Meyerhardt, RJ Mayer - New England journal of medicine, 2005 - Mass Medical Soc
JA Meyerhardt, RJ Mayer
New England journal of medicine, 2005•Mass Medical SocColorectal cancer is one of the most commonly diagnosed malignant diseases, with an
estimated 1,023,000 new cases and 529,000 deaths worldwide each year. This review
considers recently developed cytotoxic chemotherapies and biologic agents that are
effective against colorectal cancer and assesses their use as treatments for metastatic
disease and as components of adjuvant therapy.
estimated 1,023,000 new cases and 529,000 deaths worldwide each year. This review
considers recently developed cytotoxic chemotherapies and biologic agents that are
effective against colorectal cancer and assesses their use as treatments for metastatic
disease and as components of adjuvant therapy.
Colorectal cancer is one of the most commonly diagnosed malignant diseases, with an estimated 1,023,000 new cases and 529,000 deaths worldwide each year. This review considers recently developed cytotoxic chemotherapies and biologic agents that are effective against colorectal cancer and assesses their use as treatments for metastatic disease and as components of adjuvant therapy.
The New England Journal Of Medicine